09:51 AM EST - Sernova Biotherapeutics Inc. : Announced that the U.S. Food and Drug Administration has granted orphan drug designation for autologous islet transplantation for the prevention of diabetes due to total pancreatectomy. Sernova Biotherapeutics Inc.
shares T.SVA are trading up $0.01 at $0.15.
